Fibrotic diseases are often caused by chronic injuries, and are characterized by pathological over-activation of certain stages of wound healing, particularly extracellular matrix secretion. Matrix secretion is driven by the fibrotic cytokine TGF-b1 (transforming growth factorb1), which is secreted by cells as a latent complex, and must be activated extracellularly for its biological function. Plasmin is a direct proteolytic activator of TGF-b1, but puzzling results in fibrotic animal have shown that the plasmin pathway causes decreased TGF-b1. We used computational modelling and experimental tests to understand the activation of TGF-b1, by plasmin and by the matricellular glycoprotein thrombo-spondin1 (TSP1). Ordinary differential equations were used to model the dynamics of activation and feedback. TGF-b1 and TSP1 create a fibrogenic feedback loop, because TGF-b1 causes transcriptional up-regulation of TSP1, while TSP1 activates TGF-b1 through conformational change. Simulations showed that, although plasmin is a direct activator of TGF-b1, increasing doses of plasmin caused a decrease in TGF-b1 activation by cleaving TSP1 and antagonizing the TSP1-TGF-b1 positive feedback loop. Furthermore, the system was capable of bistability, switching between high and low levels of active TGF-b1. Key predictions of the mathematical model were validated in vitro with co-culture models of liver fibrosis, which showed inverse correlation between active TGF-b1 and plasmin. Bistability was demonstrated by showing hysteresis, where the same system achieved two different steady states, after being given the same two input stimuli but in opposite orders. Our model explains how plasmin can decrease or increase TGF-b1 activation, depending on the presence of TSP1. The bistable transition between plasminmediated and TSP-mediated TGF-b1 activation pathways may be relevant to the transition between inflammatory and fibrogenic phases of wound healing, suggesting novel mechanisms for addressing TGFb1-related diseases. Multiple myeloma, currently an incurable common hematological malignancy, is notorious for its recurrence and drug resistance. Our work led to the hypothesis that intercellular communications between myeloma initiating cells (MICs, a.k.a. myeloma stem cell) and bone marrow stromal cells (BMSCs) during the biomechanical remodeling of cancer stem cell niches play a key role in myeloma initiation and drug resistance. MICs prime BMSCs via SDF-1 paracrine; the activated BMSCs provide stiffer micro-environment, which boosts sustainable tumor growth under drug treatments. Understanding this pro-oncogenetic positive-feedback loop is thus crucial to the cure of the disease. In this study we used a 3D multi-scale agent-based modeling (ABM) approach to investigate the role of MIC-BMSC interactions in tumor growth and drug responses. The model is composed of four agent types, each representing a cell type: MIC, BMSC, PC (cancer progenitor cells), and MM (matured cancer cells). At intracellular level, specific signaling pathways were inferred from functional proteomics (reverse phase protein array) and gene expression data, and encapsulated into corresponding agent as ODEs. Intercellular communications were simulated on the agent-to-agent interfaces. The SDF-1 paracrine was described by PDEs of mass transfer. Intercellular events were extended to tissue level as tumor growth by a cancer stem cell lineage model (which includes MIC, PC, and MM agents). By seamlessly incorporating multi-scale events, our model quantitatively illustrated the interruption of BMSC contraction reduces the change of forming drug-resistant MIC strains and suppresses MIC colonogenesis, which was experimentally validated. Our work answered how the biomechanical remodeling of cancer stem cell niches via intercellular communications between tumor and stromal cells affects myeloma drug responses and prognosis, provided insights into myeloma development mechanisms, and cast new light on novel drug candidates and treatment strategies targeting the MIC-BMSC interactions. Magnetotactic bacteria possess the unique ability to synthesize intracellular magnetic particles, known as magnetosomes, which form magnetic chains and yield cells responsive to the Earth's ambient geomagnetic field. While several genomic regions have been identified that encode magnetosome-related genes, little is known about how these genes regulate magnetosome production.
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Magnetically-Induced Genetic Response of Magnetotactic Bacteria Mary E. Wilson 1 , Warren C. Ruder 2 , Eli Zenkov 1 , Lina M. Gonzalez 1 , Philip R. LeDuc 1 . 1 Carnegie Mellon University, Pittsburgh, PA, USA, 2 Boston University, Boston, MA, USA. Magnetotactic bacteria possess the unique ability to synthesize intracellular magnetic particles, known as magnetosomes, which form magnetic chains and yield cells responsive to the Earth's ambient geomagnetic field. While several genomic regions have been identified that encode magnetosome-related genes, little is known about how these genes regulate magnetosome production.
Here, we explore the genetic response of Magnetospirillum magneticum strain AMB-1 to an applied electromagnetic field as a means to identify genes activated by magnetic stimulation. Specifically, we examined magnetosome island (MAI), magnetotactic islet, flagellar, and cytoskeleton genes. AMB-1 cultures were subjected to a uniform, high magnetic field (10G) generated by a Helmholtz coil for 1 hour, 3 hours or 8 hours. After extracting total RNA and converting to cDNA, quantitative real time-PCR (qRT-PCR) was performed to measure relative transcription levels. After 1 hour of magnetic stimulation, gene expression was drastically down-regulated; whereas, gene expression was up-regulated after 3 hours. After 8 hours, gene expression was relatively unchanged, indicating that the AMB-1 cells may have adapted or equilibrated to the field. These results suggest that magnetic stimulation leads to altered AMB-1 signaling related to MAI activation/deactivation, as well as cytoskeletal and flagellar regulatory events. We believe these findings provide several significant genetic targets for new parts and modules toward an ultimate goal of creating magnetically-inducible synthetic gene networks.
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A Whole Cell Model of Mycoplasma Genitalium Elucidates Mechanisms of Bacterial Replication Jonathan R. Karr, Jayodita C. Sanghvi, Jared M. Jacobs, Derek N. Macklin, Markus W. Covert. Stanford University, Stanford, CA, USA. A central challenge of biology is to understand how complex phenotypes are controlled by individual molecules and their interactions. We report the first computational model which explains the life cycle of an entire organism, Mycoplasma genitalium, including metabolism, macromolecule synthesis, and cytokinesis, from the chemical interactions of molecules. The model consists of submodels of 28 cellular processes integrated through 16 cellular states and accounts for every annotated gene function. Using the model we identified the molecular determinates of cellular replication. We found the M. genitalium cell cycle is 9.0 5 0.5 h, and that most of its variance is due metabolism and thymidylate kinase expression. Additionally, we found that replication initiation and DnaA dynamics are a significant source of cell cycle variation among fast growing cells. We examined the genetic requirements of growth and found four distinct classes of single-gene deletion strains: wild-type indistinguishable, early growth cessation, slow growth decay, and non-dividing. The model correctly predicts the observed essentially of > 80% of genes. Gene-complete models will accelerate biomedical discovery and bioengineering by enabling rapid in silico experimentation, facilitating experimental design and interpretation, and guiding bioengineering and medicine. Recent studies have discovered strong differences between the dynamics of proteins and nucleic acids (RNA and DNA). This is especially clear at low hydration and low temperatures where the dynamics of methyl groups is emphasized. Methyl groups are abundant in proteins, but are absent or very rare in RNA and DNA. We present a hypothesis regarding the role of methyl groups as intrinsic plasticizers in proteins and how this can be seen as a result of evolutionary selection to facilitate protein dynamics, and therefore, activity. In support of this hypothesis we demonstrate the profound effect methyl groups have on protein dynamics and note the apparent correlation of methyl group content in different proteins classes and the role of molecular flexibility for those classes. Moreover, we have observed form literature data and simulation that the fastest methyl groups of some enzymes appear around dynamical centers such as hinges or active sites. Methyl groups are also of tremendous importance from a hydrophobicity/folding/entropy perspective. These significant Wednesday, February 29, 2012 731a
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